Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Clinical

Latest News

April 24th 2015

Dr Laura Long Says Pathways Are Part of a Bigger Care Delivery Transformation

Historically, people talk about pathways as if they are an answer, but they are really just one component to cancer care delivery, said Laura Long, MD, MPH, president at TheLongView, PC.

April 24th 2015

Adopting Goals of Care Discussions in Oncology Care Models

April 24th 2015

Why Many Doctors Don't Follow "Best Practices"

April 23rd 2015

Oncologist Highlights Primary Reasons for the High Cost of Cancer Care

By Surabhi Dangi-Garimella, PhD

April 22nd 2015

Driver of NSCLC Also Present in 23% of Small Cell Lung Cancer

Latest Videos

Bundled Payments in Oncology: What Do Payers Think?

Bundled Payments in Oncology: What Do Payers Think?

Implications of Bundled Payments in Oncology

Implications of Bundled Payments in Oncology

What Are the Constructs of Value-Based Care?

What Are the Constructs of Value-Based Care?

Can Academic Innovation in LDTs Be Halted?

Can Academic Innovation in LDTs Be Halted?

LDTs and the Political Wheelhouse

LDTs and the Political Wheelhouse

Justifying the Need for FDA Regulation of LDTs

Justifying the Need for FDA Regulation of LDTs

Payer and Consumer Response to FDA Regulation of LDTs

Payer and Consumer Response to FDA Regulation of LDTs

What Are LDTs and How Are They Regulated?

What Are LDTs and How Are They Regulated?

Introduction

Introduction

Dr C Daniel Mullins on Building Trust Between Patients and Researchers

Dr C Daniel Mullins on Building Trust Between Patients and Researchers

More News

Closing Remarks and Final Considerations

April 22nd 2015

Concerns Surrounding Enrollment into the Oncology Care Model

April 22nd 2015

The Oncology Care Model: Additional Concerns

April 22nd 2015

Analysis of the Oncology Care Model

April 22nd 2015

Drug Spend, Pricing, and Development

April 22nd 2015

Government Intervention in Drug Pricing

April 22nd 2015

Additional Pricing Considerations

April 22nd 2015

Factors That Influence Drug Pricing

April 22nd 2015

Additional Reimbursement Considerations in Oncology

April 22nd 2015

The Evolution of Buy-and-Bill

April 22nd 2015

Parity Laws and the Need for Payment Reform

April 22nd 2015

Practice-Based Pharmacies and Establishment of the COPA

April 22nd 2015

Challenges in the Management of Oral Oncolytics

April 22nd 2015

Impact of Oral Oncolytics

April 22nd 2015

340B: Policy Stakeholder Perspectives

April 22nd 2015

340B: Additional Burdens

April 22nd 2015

Influence of the 340B Drug Pricing Program

April 22nd 2015

Integrating Palliative Care Professionals Into Practice: Will It Work?

April 22nd 2015

Hospice: Trends, Challenges, and Solutions

April 22nd 2015

Integrating Palliative Care Into Oncology Practice

April 22nd 2015

Issues in Palliative Care

April 22nd 2015

Incorporating Patient-Reported Outcomes in Drug Labels

April 22nd 2015

Linking Care Outcomes With Reimbursement

April 22nd 2015

Key Measures to Improve Oncology Care and Outcomes

April 22nd 2015

Introduction: Patient-Centered Care in Oncology

April 22nd 2015

Trending on AJMC

Plastic in Personal Care Products Tied to Skin Disease and Environmental Pollution, Review Finds

Delgocitinib Coverage Could Save Health Plans $88M Over 3 Years

Three Years on Baricitinib Preserved Hair Regrowth in Severe Alopecia Areata

First FDA-Approved Inhaled Insulin for Kids Arrives With Mounting Data: Kevin Kaiserman, MD

First Clinical Evidence of Gene Editing, Epigenetic Silencing of HBV cccDNA